Current Concepts on 6-sulfo LacNAc Expressing Monocytes (slanMo)

Area of Science:

• Immunology
• Cell Biology

Background:

• The human mononuclear phagocyte system comprises dendritic cells, monocytes, and macrophages, crucial for innate and adaptive immunity.
• Monocytes are heterogeneous; the slan (6-sulfo LacNAc) marker identifies a specific subset: CD14- CD16+ non-classical monocytes, termed slan+ monocytes (slanMo).

Purpose of the Study:

• To review the identity and functions of slan+ monocytes (slanMo).
• To discuss the role of slanMo in immune surveillance, pro-inflammatory cytokine production, and cellular cross-talk.
• To examine the involvement of slanMo in chronic inflammatory diseases and cancer.

Main Methods:

• Literature review and synthesis of existing research on slan+ monocytes.
• Analysis of data concerning slanMo function in immune responses.
• Discussion of slanMo involvement in disease pathogenesis.

Main Results:

• Slan+ monocytes (slanMo) are key players in bridging innate and adaptive immunity.
• SlanMo contribute to immune surveillance through pro-inflammatory cytokine production.
• SlanMo engage in cross-talk with T cells and NK cells, influencing immune responses.

Conclusions:

• Slan+ monocytes (slanMo) possess distinct functions within the mononuclear phagocyte system.
• SlanMo play a significant role in regulating inflammatory diseases and cancer.
• Further research is needed to fully elucidate the complexities and therapeutic potential of slanMo.